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MicroRNAs regulated by lipopolysaccharide (LPS)
target genes that contribute to the inflammatory
phenotype. Here, we showed that the protein kinase
Akt1, which is activated by LPS, positively regulated
miRNAs let-7e and miR-181c but negatively regu-
lated miR-155 and miR-125b. In silico analyses and
transfection studies revealed that let-7e repressed
Toll-like receptor 4 (TLR4), whereas miR-155 re-
pressed SOCS1, two proteins critical for LPS-driven
TLR signaling, which regulate endotoxin sensitivity
and tolerance. As a result, Akt1/ macrophages ex-
hibited increased responsiveness to LPS in culture
and Akt1/ mice did not develop endotoxin toler-
ance in vivo. Overexpression of let-7e and suppres-
sion of miR-155 in Akt1/ macrophages restored
sensitivity and tolerance to LPS in culture and in
animals. These results indicate that Akt1 regulates
the response of macrophages to LPS by controlling
miRNA expression.
INTRODUCTION
Activation of macrophages by lipopolysaccharide (LPS) initiates
feedback inhibitory loops that aim in establishing tolerance to
a subsequent LPS stimulus. Negative feedback signals either
inhibit the expression of genes that are required for the response
to LPS, such as the LPS receptor Toll-like receptor 4 (TLR4), or
promote the expression of genes that inhibit the response,
such as suppressor of cytokine signaling 1 (SOCS1) and IL-1
receptor-associated kinase-M (IRAK-M). Thus, within a few
hours from the start of LPS stimulation, the expression of the
LPS receptor TLR4 decreases, to rise again 24 to 48 hr later
(Medvedev et al., 2000; Nomura et al., 2000). Negative regulators
of TLR4 signaling such as SOCS1 (Kinjyo et al., 2002; Nakagawa
et al., 2002) and IRAK-M (Kobayashi et al., 2002) are upregulated
within 2 hr from the start of the stimulation. The net effect of the
downregulation of TLR4 and the induction of negative regulatory
molecules is the emergence of tolerance to LPS restimulation.
Mutations that interfere with these negative regulatory loops220 Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc.promote hyperresponsiveness to LPS and inhibit the develop-
ment of endotoxin tolerance (Kinjyo et al., 2002; Nakagawa
et al., 2002; Kobayashi et al., 2002). One pathway that plays a
critical role in feedback inhibition of LPS signals is the phosphoi-
nositide-3 kinase (PI-3K)-Akt kinase signaling pathway (Fukao
and Koyasu, 2003; Guha and Mackman, 2002; Luyendyk et al.,
2008; Williams et al., 2006; Zhang et al., 2007).
Akt (also known as PKB) is a family of serine-threonine protein
kinases that are activated by PI-3K and that play key regulatory
roles in a host of cellular functions including cell survival, cell
proliferation, differentiation, and intermediary metabolism. Stim-
ulation of macrophages with the TLR4 agonist LPS activates
PI-3K and its downstream targets, including Akt kinases. Thus,
activation of the PI-3K-Akt pathway suppresses LPS-activated
MAPK and NF-kB signaling cascades in monocytes and
dendritic cells, resulting in decreased production of TNF-a and
other cytokines (Fukao et al., 2002; Guha and Mackman,
2002). Moreover, inhibition of Glucogen Synthase Kinase-3
(GSK3) in vivo, a kinase that is phosphorylated and inactivated
by Akt, results in resistance to endotoxin shock (Martin et al.,
2005), suggesting that inhibition of Akt will render mice more
sensitive to LPS.Consistentwith these observations, Akt overex-
pression in lymphocytes prevents sepsis-induced apoptosis and
improves survival in a cecal ligation and puncture (CLP) model of
polymicrobial sepsis (Bommhardt et al., 2004). Moreover,
whereas macrophages deficient of the p85a subunit of PI-3K
are hyperresponsive, macrophages deficient of PTEN, a phos-
phatase that antagonizes PI-3K, are hyporesponsive to signals
associated with macrophage activation (Luyendyk et al., 2008).
MicroRNAs (miRNAs) play a central role in gene expression.
Mechanistically, miRNAs pair with partially complementary
sequences in target mRNAs and regulate their stability and/or
translation. Changes in the expression of miRNAs during the
response to extracellular signals, or during differentiation or
oncogenic transformation, allow miRNAs to regulate these
processes. Recent studies have identified miRNAs as critical
regulators of immune responses including inflammation (Balti-
more et al., 2008; Chong et al., 2008; Cobb et al., 2006; Liston
et al., 2008; Lu et al., 2009; Xiao and Rajewsky, 2009; Zhou
et al., 2008). In addition, LPS stimulation upregulates or
represses the expression of miRNAs in macrophages. Among
the LPS-responsive miRNAs characterized to date, miR-155
is upregulated in response to LPS (O’Connell et al., 2007;
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Akt1 Regulates Endotoxin Tolerance via miRNAsFigure 1. MiRNAs Are Differentially Induced by LPS in the Absence
of Akt1
(A) Primary macrophages from Akt1+/+ and Akt1/mice were stimulated for 4
hr with LPS, and differences in the miRNA profile were analyzed by microarray
and presented as a heat-map in which green indicates suppression and red
indicates induction compared to untreated cells.
(B) Comparison of let-7e, miR-155, miR-181c, and miR-125b expression in
stimulated and unstimulated Akt1+/+ and Akt1/ macrophages. (n = 3; ±
SEM); **p < 0.01 and ***p < 0.001. Results are representative of three indepen-
dent experiments.
(C) Expression of the corresponding pri-miRNAs of let-7e, miR-155, miR-181c,
and miR-125b was measured in LPS-stimulated Akt1+/+ and Akt1/ primary
BMDMs (n = 3; ± SEM) ***p < 0.001 compared to LPS-stimulated Akt1+/+
macrophages; ###p < 0.001 compared to unstimulated Akt1+/+ macrophages.
Results are representative of three independent experiments.
(D) Primary BMDMs were infected with a retrovirus expressing myrAkt1 and
72 hr later stimulated with LPS. Let-7e, miR-155, and miR-125b expression
was measured 24 hr after stimulation (n = 3; ± SEM); ***p < 0.001 compared
to mock-transfected and non-LPS-treated cells, ###p < 0.001 compared to
mock-transfected LPS-treated cells at the same time point. Results are repre-
sentative of two independent experiments.Tili et al., 2007), promoting the expression of TNF-a and destabi-
lization of PU.1 (Vigorito et al., 2007), a keymediator of monocyte
and macrophage differentiation and TLR4 transcription (Roger
et al., 2005; Tsatsanis et al., 2006; Vigorito et al., 2007). MiR-
155 also targets and suppresses SOCS1, a critical regulator of
STAT signaling, in regulatory T cells (Lu et al., 2009) and the
inositol phosphatase SHIP1 (O’Connell et al., 2009). In contrast,
miR-125b inhibits the expression of TNF-a and is downregulated
in LPS-treated macrophages (Tili et al., 2007).
Given the importance of Akt in the negative feedback of TLR4
signaling, we examined the role of Akt1, one of the three Akt iso-
forms, in miRNA expression in LPS-activated macrophages. In
mammals, the Akt family consists of three isoforms, Akt1
(PKBa), Akt2 (PKBb), and Akt3 (PKBg), which are functionally
distinct despite their sequence similarities (Cho et al., 2001;
Easton et al., 2005; Mao et al., 2007; Maroulakou et al., 2007;
Yang et al., 2005). Recent studies showed that Akt1 ablation in
mice gives rise to a proinflammatory phenotype resulting in
enhanced atherogenesis (Fernandez-Hernando et al., 2007).
Here, we examined the role of Akt1 in the regulation of miRNA
expression in LPS-stimulated macrophages. miRNA arrays re-
vealed that LPS-treated Akt1/ macrophages failed to induce
let-7e and expressed higher amounts of miR-155, in contrast
to Akt1+/+ macrophages. In silico analysis and transfection
studies revealed that let-7e controlled TLR4 and miR-155
SOCS1 and that these miRNAs were under the control of Akt1.
As a result, Akt1/ macrophages were hyperresponsive to
LPS and failed to develop endotoxin tolerance in culture and
in vivo. Introduction of these miRNAs in Akt1/ macrophages
restored their response to LPS, indicating that Akt1 controls
macrophage responsiveness to LPS endotoxin tolerance by
regulating the expression of miRNAs.
RESULTS
Akt1 Regulates LPS-Induced miRNA Expression
in Macrophages
LPS-generated signals in macrophages regulate miRNAs that
control the expression of molecules involved in TLR signaling
(O’Connell et al., 2007; Tili et al., 2007). Because LPS signals
activate Akt, we questioned whether Akt1 ablation affects the
expression of microRNAs that regulate TLR signals in unstimu-
lated and LPS-stimulated macrophages. miRNA expression
was analyzed with an array containing 365 miRNAs, as de-
scribed in the Experimental Procedures. Figure 1A depicts
miRNAs, the expression of which was affected in the presence
or absence of LPS and Akt1, in thioglycollate-induced primary
macrophages from Akt1+/+ and Akt1/ mice. The results were
confirmed by real-time RT-PCR and showed that LPS promoted
the expression of let-7e and miR-181c in Akt1+/+ cells only.
In addition, LPS upregulated miR-155 and downregulated
miR-125b, and in the absence of Akt1, LPS failed to suppress
miR-125b. In contrast, the induction of miR-155 was more
pronounced in the absence of Akt1 (Figure 1B). In unstimulated
Akt1/ macrophages, let-7e was expressed at greater
amounts. However, the induction of let-7e by LPS was abro-
gated in the absence of Akt1 (Figure 1B). Expression of let-7e
and miR-155 in Akt1+/+ cells was induced after 3 hr of LPS treat-
ment and remained high at 24 hr after stimulation (data notImmunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc. 221
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Akt1 Regulates Endotoxin Tolerance via miRNAsFigure 2. Akt1 Regulates the Expression of TLR4 and
SOCS1
(A) Protein expression of TLR4 in primary thioglycollate-eli-
cited peritoneal macrophages from Akt1/ and Akt1+/+
mice treated with 1 mg/ml LPS for 24 hr was determined by
flow cytometry analysis with a TLR4-PE conjugated Ab.
Results are representative of three independent experiments.
(B) Protein expression of TLR4 in primary thioglycollate-eli-
cited peritoneal macrophages from Akt1+/+ and Akt1/
mice measured by flow cytometry analysis.
(C) mRNA expression of TLR4 in macrophages from Akt1+/+
and Akt1/ mice treated with LPS (n = 3; ± SEM). Results
are representative of three independent experiments.
(D and E) Primary thioglycollate-elicited peritoneal macro-
phages from Akt1+/+ and Akt1/ mice were treated with
LPS for 6, 12, or 24 hr. The LPS- induced expression of
SOCS1 protein were measured by (D) immunoblotting, and
(E) mRNA were measured by real-time PCR (n = 3; ± SEM);
*p < 0.05 and ***p < 0.001 compared to unstimulated cells of
the same genotype; #p < 0.05, ##p < 0.01, and ###p < 0.001
compared to wild-type LPS-treated cells at the same time
point. Results are representative of three independent exper-
iments.shown). LPS did not induce let-7e even at 24 hr from the start of
stimulation in Akt1/ macrophages (data not shown).
miRNAs can be regulated at the transcriptional or posttran-
scriptional level. Transcriptional activation of the miRNA locus
results in generation of the pri-miRNA, which is subsequently
processed to give rise to pre-miRNA and then to the mature
miRNA. To determine whether Akt1 affects let-7e, miR-155,
miR-181c, and miR-125b at the transcriptional or posttranscrip-
tional level, we measured expression of pri-let-7e, pri-miR-155,
pri-miR-181c, and pri-miR-125b in LPS-stimulated Akt1+/+ and
Akt1/ macrophages. The results showed that LPS increased
the expression of pri-let-7e, pri-miR-155, and pri-miR-181c,
whereas it suppressed pri-miR-125b. Ablation of Akt1 resulted
in reduced pri-let-7e and pri-miR-181c, increased pri-miR-155
and abolished the suppression of pri-miR-125b (Figure 1C).
We could, therefore, conclude that Akt1 regulates thesemiRNAs
at the level of transcription.
To confirm that Akt1 controls the expression of let-7e,
miR-155, miR-181c and miR-125b, we infected primary bone
marrow-derived macrophages (BMDMs) with a retrovirus ex-
pressing myristoylated Akt1 (myrAkt1), a constitutively active
mutant of Akt1, andGFP under independent promoters, to deter-
mine infection efficiency. Almost all cells expressed GFP 72 hr
after infection (data not shown). RNA was isolated and the
expression of let-7e, miR-155, miR-181c and miR-125b was
determined. Active Akt1 induced the basal expression of let-7e
and mir-181c and suppressed the basal expression of miR-
155, whereas it had no effect on the basal expression of miR-
125b (Figure 1D). In LPS-stimulated cells, expression of myrAkt1
resulted in augmented let-7e and miR-181c expression,
augmented suppression of miR-125b, and reduced induction of
miR-155 (Figure 1D), confirming that these miRNAs are under
the control of Akt1. The same results were observed in the
Raw264.7 macrophage cell line when infected with a myr-Akt-
GFP retrovirus (data not shown) or transiently transfected with
a myr-Akt1-GFP plasmid, and GFP-positive cells were sorted
by flow cytometry and collected for further analysis (data not
shown).222 Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc.To identify potential targets for these miRNAs, we screened
their sequences against the mouse genome database, by using
the miRNA target identification programs miRBase, PicTar, and
TargetScan v.4.0, as described in the Experimental Procedures.
This analysis identified TLR4 as a potential let-7e target, TNF-a
as potential target of miR-125b, and TNFSF11 (also known as
RANKL) as a potential target of miR-181c (Figure 1E). In addition
to known miR-155 targets, IKK3, TRAF6, and RIPK (Tili et al.,
2007), this analysis identified SOCS1 as a potential miR-155
target (Figure S1). Our findings were consistent with previously
published data showing that the let-7e isoform let-7i targets
and promotes degradation of TLR4 mRNA in human cholangio-
cytes (Chen et al., 2007) and that miR-155 targets and
suppresses SOCS1 in mouse regulatory T cells (Lu et al., 2009).
Akt1 Mediates LPS-Induced TLR4
and SOCS1 Regulation
TLR4 andSOCS1 are key regulators ofmacrophage sensitivity to
LPS, and their expression affects the magnitude of the response
and, therefore, the amounts of proinflammatory mediators.
Because Akt1 affects let-7e and miR-155 and our predictions
suggest that let-7e targets TLR4 and miR-155 targets SOCS1,
we examined whether TLR4 and SOCS1 are regulated by Akt1.
We tested whether Akt1 ablation affects TLR4 and SOCS1
expression. If the expression of TLR4 in macrophages is sup-
pressed by let-7e, one would expect that LPS stimulation would
downregulate TLR4 in wild-type but not in Akt1/ macro-
phages. In addition, the expression of TLR4 in unstimulated
Akt1/ macrophages would be lower than in unstimulated
wild-type macrophages because of the higher basal let-7e
expression in the Akt1/ cells. Flow cytometric and real-time
RT-PCR analysis of unstimulated and LPS-stimulated wild-
type and Akt1/ macrophages confirmed these predictions
(Figures 2A–2C), suggesting that let-7e indeed functions as
a physiological inhibitor of TLR4 expression. LPS transiently
enhanced TLR4 mRNA expression in Akt1/ macrophages
(Figure 2C); such an effect did not become evident at the protein
level (Figure 2A).
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pressed by miR-155, one would expect that LPS stimulation
would upregulate the expression of SOCS1 more efficiently in
wild-type than in Akt1/ macrophages because LPS-treated
Akt1/ cells expressed more miR-155 than Akt1+/+ cells. It is
important to note that SOCS1 expression is induced by LPS
and is elevated, despite its role in negative regulation of LPS
responsiveness. In this case, miR-155 modulates the amount
of SOCS1 induction. Immunoblot and real-time RT-PCR analysis
revealed that LPS-treated Akt1/ macrophages expressed
lower amounts of SOCS1 compared to their wild-type counter-
parts (Figures 2D and 2E), suggesting that Akt1, via suppression
of miR-155, augments SOCS1 expression.
To confirm that TLR4 and SOCS1 are regulated by Akt1, we
determined their expression in primary BMDMs infected with a
retrovirus expressing myrAkt1 and GFP, as described in Fig-
ure 1C and in the Experimental Procedures. Cells were analyzed
for expression of TLR4 and SOCS1. The results indicated that
myrAkt1 suppressed basal TLR4 expression (Figure 3A) and
further augmented LPS-induced TLR4 suppression (Figures 3B
and 3C). In addition, myrAkt1 augmented LPS-induced SOCS1
protein and mRNA expression (Figures 3D and 3E). The same
results were obtained in Raw264.7 macrophages infected with
a retrovirus expressing myr-Akt1 or after transient transfection
of myrAkt1 (data not shown). Thus, these results support our
observation that Akt1 suppresses LPS-induced miR-155
(Figure 1D), resulting in increased LPS-induced SOCS1 (Figures
3D and 3E).
Let-7e Targets TLR4 and miR-155 Targets SOCS1
Because Akt1 controls the expression of let-7e, miR-155, and
their predicted targets TLR4 and SOCS1, respectively, we
wanted to confirm that TLR4 and SOCS1 are indeed regulated
by these miRNAs. On the basis of the sequence alignment of
let-7e with TLR4 mRNA (Figure S2A), the miRNA programs
Figure 3. Overexpression of Akt1 Affects TLR4 and
SOCS1 Expression
(A) BMDMs from C57BL/6mice were infected with a retrovirus
expressing myrAkt1 and GFP. The expression of TLR4 protein
was measured in GFP-positive, myrAkt1-overexpressing cells
by flow cytometry; control versus mock-transfected cells are
shown.
(B and C) BMDMs overexpressing myrAkt1 were stimulated
with LPS for 24 hr; (B) TLR4 protein was measured by flow
cytometry, and (C) TLR4 mRNA was measured by real-time
RT-PCR; control:mock transfected cells without LPS stimula-
tion are shown.
(D and E) SOCS1 expression in myr-Akt1 transfected BMDMs
in the presence or absence of LPS was measured at the (D)
protein and (E) mRNA level (n = 3; ± SEM); *p < 0.05 and
**p < 0.01. Results are representative of three independent
experiments.
mentioned above predicted that TLR4 is a likely
target of let-7e. To validate the finding that let-7e
suppresses TLR4, we transfected RAW264.7
macrophages with let-7e or with its antisense
counterpart as-let7e. Control cells were trans-
fected with scrambled miRNA (SCR-miRNA).
Real-time RT-PCR with total-cell RNA harvested at the indicated
time points revealed that whereas let-7e inhibited, as-let-7e
enhanced the expression of TLR4 (Figures 4A and 4B). Let-7e
was effectively suppressed by as-let-7 within 12 hr after trans-
fection (Figure S3). To confirm the in silico prediction that let-
7e interacted with the 30 UTR of TLR4, we cloned 383 bp of the
30 UTR of TLR4 that included the let-7e-binding site downstream
of the luciferase gene (TLR4-UTR-luc) and cotransfected them
with let-7e or its antisense inhibitor as-let-7e in Raw264.7
macrophages. The results indicated that let-7e suppressed
whereas as-let-7e enhanced luciferase expression and activity,
thereby showing a direct interaction between let-7e and the 30
UTR of TLR4 (Figure 4C). Mutation at the seed sequence of the
TLR4-30 UTR where let-7e was predicted to bind (mutTLR4-
UTR-luc) abolished suppression by let-7e (Figure 4C).
Sequence alignment of miR-155with SOCS1mRNA predicted
that SOCS1 is a likely target of miR-155 (Figure S2B). Earlier
studies indicated that miR-155 and SOCS1 interacted in regula-
tory T cells and in 293T cells (Lu et al., 2009). To confirm that
miR-155 also regulates SOCS1 in macrophages, we transfected
RAW264.7macrophages with as-miR-155 or SCR-miRNA. Real-
time RT-PCR with total-cell RNA harvested at the indicated time
points revealed that as-miR-155 enhanced the expression of
SOCS1 both in naive (Figure 4D) and LPS-activated (Figure 4E)
RAW264.7 cells. miR-155 was effectively suppressed by as-
miR-155 within 24 hr after transfection (Figure S4). To confirm
that miR-155 interacted with the 30 UTR of SOCS1, we cloned
a 397 bp fragment of the SOCS1 30 UTR that contained the
miR-155-binding site downstream the luciferase gene (SOCS1-
UTR-luc) and cotransfected it with miR-155 or as-miR-155 in
Raw264.7 macrophages. The results indicated that miR-155
suppressed whereas as-miR-155 enhanced luciferase expres-
sion and activity and that mutation of the seed sequence for
miR-155 at the 30UTR of SOCS1 (mutSOCS1-UTR-luc) abol-
ished the suppression (Figure 4F). Thus, these results supportImmunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc. 223
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Akt1 Regulates Endotoxin Tolerance via miRNAsFigure 4. Let-7e and miR-155 Regulate TLR4 and SOCS1, Respectively
(A) Raw264.7 macrophages were transfected with let-7e or SCR-miRNA, and expression of TLR4 mRNA was measured at different time points by real-time RT-
PCR.
(B) Raw264.7 macrophages were transfected with as-let7e or SCR-miRNA, and TLR4 mRNA was measured at different time points.
(C) Raw264.7 macrophages were transfected with a luciferase construct containing the 30 UTR of TLR4 (TLR4-UTR-luc) or with the same construct containing
a mutant seed sequence at the let-7e-binding site (mutTLR4-UTR-luc) in the presence or absence of let-7e or as-let-7e.
(D) As-miR-155 was transfected in Raw264.7 macrophages and SOCS1 mRNA was measured by real-time RT-PCR.
(E) As-miR-155 or SCR-miRNA was transfected in macrophages stimulated with LPS, and SOCS1 expression was measured by real-time RT-PCR.
(F) Raw264.7macrophages were transfectedwith a luciferase construct containing the 30 UTR of SOCS1 (SOCS1-UTR-luc) or with the same construct containing
a mutant seed sequence at the miR-155-binding site (mutSOCS1-UTR-luc) in the presence or absence of miR-155 or as-miR-155. Results depict the average
(±SEM) of three independent transfections; **p < 0.01 and ***p < 0.001 compared to time 0 in the mRNA quantification experiments and to SCR-miRNA-trans-
fected cells in the luciferase experiments.the in silico prediction that let-7e and miR-155 directly targeted
the 30 UTR of TLR4 and SOCS1, respectively.
Let-7e, miR-155, and Akt1 Regulate Endotoxin
Sensitivity and Tolerance
To determine whether differential expression of the microRNAs
let-7e and miR-155 affects the magnitude of macrophage
response to LPS, we transfected Raw264.7 macrophages
with as-let-7e, let-7e, miR-155, as-miR-155, or combinations
of these prior to LPS stimulation, measured the proinflamma-
tory mediators TNF-a, IL-6, IL-17, IP-10, MCP-1, MIP-1a, and
PGE2, and compared them to SCR-miRNA-transfected cells.
Efficacy of let-7e and miR-155 suppression by as-let-7e and
as-miR-155 was evaluated by real-time RT-PCR (data not
shown). The results showed that introduction of as-let-7e
augmented whereas let-7e suppressed the response to LPS.224 Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc.In contrast, introduction of as-miR-155 suppressed whereas
miR-155 augmented the LPS response. Combination of as-
let-7e and miR-155 exhibited the highest increase in proinflam-
matory mediators, whereas combination of let-7e and as-miR-
155 significantly reduced all proinflammatory mediators
(Figure 5A).
The preceding data suggest that differential expression of let-
7e, miR-155, and their target genes TLR4 and SOCS1 may
contribute to enhanced induction of proinflammatory cytokines
by LPS in Akt1/ compared to Akt1+/+ macrophages. Stimula-
tion of Akt1+/+ and Akt1/ thioglycollate-elicited peritoneal
macrophages with LPS for 24 hr resulted in increased expres-
sion of proinflammatorymediators. However, ablation of Akt1 re-
sulted in increased secretion of the proinflammatory cytokines
TNF-a, IL-6, and IL-17 and the proinflammatory chemokines
IP-10, MIP-1a, and MCP-1, and also increased production of
Immunity
Akt1 Regulates Endotoxin Tolerance via miRNAsFigure 5. Let-7e and miR-155 and Akt1 Control Macrophage Sensitivity to LPS
Raw264.7 cells were transfected with let-7e,mir-155, as-let-7e, as-miR-155, or combinations of these. As shown in (A), TNF-a, IL-6, IL-17, IP-10,MCP-1,MIP-1a,
and PGE2 were measured at 12 and 24 hr after LPS stimulation (n = 3; ± SEM) *p < 0.05, **p < 0.01, and ***p < 0.001 compared to control-transfected cells stim-
ulated with LPS for the same time period. Results are representative of three independent experiments. As shown in (B), thioglycollate-elicitedmacrophages from
Akt1+/+ andAkt1/mice were stimulated with LPS for 24 hr; TNF-a, IL-6, IL-17, IP-10, MCP-1, MIP-1a, PGE2, and NOweremeasured in the culture supernatants
(n = 3; ± SEM) **p < 0.01 and ***p < 0.001 compared to Akt1+/+ cells. Results are representative of five independent experiments for TNF-a and IL-6 and two
independent experiments for IL-17, IP-10, MCP-1, MIP-1a, PGE2, and NO.PGE2 and NO (Figure 5B). Similar results were obtained with
BMDMs from Akt1+/+ and Akt1/ mice (data not shown), con-
firming that homologous deletion of Akt1 confers increased
sensitivity to LPS.Let-7e and miR-155 Mediate LPS Hyperresponsiveness
in Akt1/ Macrophages
Because Akt1 regulated let-7e and miR-155, and LPS-activated
Akt1/ macrophages expressed increased amounts of TLR4Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc. 225
Immunity
Akt1 Regulates Endotoxin Tolerance via miRNAsand reduced amounts of SOCS1, we wanted to confirm that the
Akt1 phenotype wasmediated by thesemiRNAs. To this end, we
transfected let-7e and as-miR155 or SCR-miRNA in primary
BMDMs from Akt1/ mice and determined expression of
TLR4 and SOCS1 upon LPS stimulation. The results showed
that transfection of let-7e in Akt1/macrophages restored their
ability to suppress TLR4 expression in response to LPS (Figures
6A and 6B). Similarly, transfection of as-miR-155 in Akt1/
macrophages resulted in comparable levels of SOCS1 to those
observed in Akt1+/+ mice (Figures 6C and 6D).
To confirm that the LPS hyperresponsiveness observed in
Akt1/ macrophages was due to altered expression of let-7e
and miR-155, we simultaneously transfected Akt1/ BMDMs
with let-7e and as-miR-155 or SCR-miRNA and stimulated
them with LPS for 12 or 24 hr. TNF-a and IL-6 were measured
in the culture supernatants and showed that transfection of let-
7e and as-miR-155 restored the response of Akt1/ macro-
phages to LPS (Figures 6E and 6F), suggesting that Akt1 controls
the responsiveness of macrophages to LPS via let-7e and miR-
155. As-miR-155 effectively suppressed miR-155 in BMDMs
(data not shown).
Figure 6. Altered LPS Response of Akt1/
Macrophages Depends on Let-7e and
miR-155
(A–D) Akt1/macrophages were transfected with
let-7e, as-miR-155, or a combination of the two
and stimulated with LPS. Expression of TLR4 (A)
mRNA and (B) protein and SOCS1 (C) mRNA and
(D) protein was measured (±SEM); **p < 0.01 and
***p < 0.001 compared to SCR-miRNA-trans-
fected Akt1/ cells at the same time point;
###p < 0.001 compared to Akt1+/+ macrophages
at time 0.
(E and F) Production of (E) TNF-a and (F) IL-6 was
measured by ELISA in the culture supernatant.
Results are representative of three independent
experiments (±SEM); **p < 0.01 and ***p < 0.001
compared to SCR-miRNA-transfected Akt1/
cells at the same time point.
Ablation of Akt1 Inhibits the
Induction of Endotoxin Tolerance
Given that the increased response of
Akt1/ macrophages to LPS resulting
from reduced induction of SOCS1 and
absence of TLR4 suppression are hall-
mark events for the development of
endotoxin tolerance, we investigated
whether ablation of Akt1 interferes with
the development of endotoxin tolerance.
When macrophages are exposed to an
initial LPS stimulus, they initiate tolerance
mechanisms and upon restimulation,
they fail to effectively produce proinflam-
matory cytokines. BMDMs were, there-
fore, tolerized with an initial LPS treat-
ment for 6 hr, culture media were
changed, and cells were exposed to a
second LPS stimulus for different time
periods. The results showed that whereas Akt1+/+ macrophages
became tolerant to subsequent LPS stimulation and produced
low amounts of proinflammatory cytokines, Akt1/ macro-
phages did not and continued to produce proinflammatory cyto-
kines in response to the second LPS stimulus (Figures 7A and
7B). To evaluate the contribution of let-7e and miR-155 in the
abrogation of LPS-tolerance observed in Akt1/macrophages,
we transfected Akt1/ BMDMs with let-7e and as-miR-155 or
SCR-miRNA, tolerized them with a first LPS stimulus, and re-
stimulated them with LPS for different time periods. Proinflam-
matory cytokines were measured in culture supernatants and
showed that introduction of let-7e and suppression of miR-155
in Akt1/ macrophages restored tolerance to LPS (Figures 7A
and 7B).
LPS-induced cytokine production in culture is the result of
continuous stimulation because LPS remains active throughout
the stimulation period; thus, the differences in cytokine produc-
tion observed in LPS-treated Akt1/ macrophages in culture
are, at least in part due to the defects in negative regulatory
mechanisms. In vivo, LPS is rapidly neutralized by serum lipo-
proteins (Flegel et al., 1993; Freudenberg et al., 1980), allowing226 Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc.
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activation. Intraperitoneal (i.p.) inoculation of a cohort of 12 wild-
type and 9 Akt1/ mice with 1.5 mg LPS per 25 g of body
weight, being the minimal lethal dose as determined by titration
experiments (see Experimental Procedures), revealed no signif-
icant differences in LPS sensitivity between the two genotypes
(Figure 7C). Measuring TNF-a and IL-6 in the serum revealed
no statistically significant differences between the two groups
(Figure 7D). This result suggested that Akt1 may be redundant
during the initial phase of macrophage activation but is required
at later stages for the induction of miRNAs and development of
endotoxin tolerance. Earlier studies have shown that overex-
pression of Akt1 suppresses ERK1, ERK2, and NF-kB activation
in LPS-stimulated macrophages. We, thus, treated Akt1/ and
Akt1+/+ macrophages with LPS and measured ERK1 and ERK2
phosphorylation and IkBa degradation. LPS-activated Akt1/
macrophages exhibited increased ERK1/2 activation (Figure S5)
but no change in IkBa degradation (Figure S6), suggesting that
Akt1 plays an inhibitory role in early TLR4 signals, but its ablation
is not sufficient to suppress proinflammatory cytokine produc-
tion at the early stages of endotoxemia.
To determine whether Akt1 is essential for the development
of endotoxin tolerance in mice, we inoculated another cohort
of 9 Akt1+/+ and 11 Akt1/ mice with a sublethal dose of LPS
(500 mg/25 g body weight) i.p. and 24 hr later, with a lethal
dose of LPS (1.5 mg/25 g body weight), also i.p. The results
showed a significant delay in endotoxin-induced mortality in
wild-type but not in Akt1/ mice (Figure 7E) accompanied by
increased TNF-a and IL-6 in the serum of Akt1/ mice (Fig-
ure 7F), suggesting that the ablation of Akt1 inhibits the induction
of endotoxin tolerance in vivo.
To address the involvement of let-7e and miR-155 in endo-
toxin tolerance in vivo, we treated Akt1+/+ and Akt1/ mice
with a tolerogenic sublethal dose of LPS. The expression of
let-7e, miR-155, and their pri-miRNA precursors was measured
in macrophages, which were isolated by cell sorting 6 hr later
from the spleens of these animals. let-7e was induced in Akt1+/+
but not in Akt1/ macrophages, and miR-155 was induced in
Akt1+/+ and super-induced in Akt1/macrophages (Figure 7G).
Expression of TLR4 was measured in macrophages from the
same mice at both the mRNA and protein levels. TLR4 was
downregulated in Akt1+/+ but not in Akt1/ macrophages (Fig-
ures 7H and 7I). Finally, the expression of SOCS1 at the mRNA
and protein levels was measured in macrophages and spleen
lysates, respectively. SOCS1 was induced to express higher in
Akt1+/+ than in Akt1/ macrophages (Figures 7H and 7I). These
results confirmed that let7e,miR-155, and their targets are differ-
entially regulated in vivo, in Akt1+/+ and Akt1/ mice inoculated
with a sublethal, tolerogenic dose of LPS.
To confirm that let7e and miR-155 were responsible for Akt1-
dependent endotoxin tolerance in vivo, we first depleted C57BL/
6 mice of macrophages, by using liposome-encapsulated clodr-
onate. The macrophage-depleted mice were reconstituted with
Akt1+/+ or Akt1/ BMDMs, transfected with let-7e and as-
miR-155, or SCR-miRNA. To monitor the reconstitution of
macrophage-depleted animals, we transfected donor BMDMs
with FAM-labeled SCR-RNA, which rendered them fluorescent
(see Figure S7). Experimental mice were inoculated with a suble-
thal dose of LPS and inoculated 24 hr later with the LD50 dose,as determined by titration experiments (see Supplemental
Experimental Procedures). The results showed that mice recon-
stituted with Akt1/ macrophages, or Akt1/ macrophages
transfected with SCR-miRNA, were not tolerant to the second
dose of LPS. However, mice reconstituted with BMDMs trans-
fected with let-7e and as-miR-155 became tolerant, as indicated
by their resistance to LPS determined by survival and cytokine
production (Figure S8). We, therefore, conclude that Akt1
contributes to endotoxin tolerance in vivo by regulating the
expression of let-7e and miR-155.
DISCUSSION
LPS stimulation ofmacrophages results in differential expression
of miRNAs that contribute to the inflammatory response.
Evidence presented here confirmed these observations and
identified miRNAs that are controlled by Akt1. Moreover, we
provide evidence associatingmiRNA expression with the regula-
tion of molecules controlling macrophage sensitivity and toler-
ance to LPS.
The present study identified let-7e and miR-181c to be posi-
tively regulated by Akt1 in LPS-activatedmacrophages, whereas
miR-125b and miR-155 to be negatively regulated. Earlier
studies had shown that let-7i, an isoform of let-7e, targets
TLR4 in human cholangiocytes (Chen et al., 2007), that miR-
155 targets TNF-a, PU.1, SHIP1, and SOCS1 (Lu et al., 2009;
Tili et al., 2007; Vigorito et al., 2007), and that miR-125b targets
TNF-a (Tili et al., 2007). Our in silico analysis showed that let-7e
targets TLR4, that miR-155 targets SOCS1, and that miR-181c
targets TNFSF11 (RANKL). MiR-181c is suppressed in leukemia
cells (Yu et al., 2006) and in response to TPA in HL-60 cells (Chen
et al., 2008). The present work showed that miR-181c is induced
by LPS, and such an induction may contribute to LPS-induced
RANKL suppression (Maruyama et al., 2006). Akt1 deletion re-
sulted in inhibition of miR-181c induction, whereas RANKL was
further inhibited in the absence of Akt1 (data not shown), sug-
gesting that Akt1 controls RANKL through a more complex
mechanism. LPS also suppressed miR-125b in an Akt1-depen-
dent manner, whereas expression of the miR-125b target
TNFa was augmented in Akt1/ macrophages. It is likely that
the higher expression of miR-125b in Akt1/ macrophages
cannot effectively suppress TNF-a and that other targets of the
same miRNA may positively contribute in LPS signaling. Our
studies focused on let-7e and miR-155 because they control
genes that regulate macrophage responsiveness to LPS.
Indeed, Akt1 ablation resulted in hyperresponsiveness to LPS.
Previous studies have shown that PI-3K and its downstream
target Akt are activated by TLR4 signals and that they may func-
tion in a feedback loop that inhibits the response to both the
primary and secondary exposure to TLR4 activators (Fukao
and Koyasu, 2003). These inhibitory effects may be mediated
by PI-3K targets other than Akt, or by Akt. We, therefore, exam-
ined the phenotypic consequences of a single Akt isoform abla-
tion. Akt1 is only partly redundant during the early stages of
macrophage activation because its deletion does not affect
primary endotoxemia and NF-kB activation, but it augments
ERK1 and ERK2 activation during the initial response to LPS,
although it appears to be essential at later stages for the devel-
opment of endotoxin tolerance. As a result, ablation of Akt1,Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc. 227
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(A and B) BMDMs from Akt1/ mice were transfected with SCR-miRNA or with let-7e and as-miR-155, stimulated with LPS for 6 hr, and restimulated with LPS.
(A) TNF-a and (B) IL-6 wasmeasured in the culture supernatant (n = 3; ± SEM); **p < 0.01 and ***p < 0.001 compared toAkt1/macrophages transfectedwith let-
7e and as-miR-155 and compared to Akt1+/+ macrophages. Results are representative of three independent experiments.
(C) Akt1/ (n = 9) and Akt1+/+ (n = 12) mice were treated once with 1.5 mg/25 gr LPS, and survival was monitored.
(D) TNF-a and IL-6 were measured in the serum 2 and 4 hr after LPS administration, respectively. Results represent measurements of six mice per group (±SEM).
(E) Akt1/ (n = 11) and Akt1+/+ (n = 9) mice were treated with 500 mg/25 gr for 24 hr and then restimulated with LPS at 1.5 mg/25 gr. Survival of animals was
monitored.
(F) Serum TNF-a and IL-6 was measured 1 and 4 hr after LPS restimulation, respectively. Results represent measurements from five mice per group (±SEM);
*p < 0.05 and **p < 0.01.
(G) F4/80+ macrophages were isolated from the spleen of LPS-injected (500 mg/25 g) Akt1+/+ and Akt1/mice 6 hr after injection and let-7e, miR-155, pri-let-7e,
and pri-miR-155 were measured (n = 3; ± SEM). Results are representative of three mice per strain.228 Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc.
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Akt1 Regulates Endotoxin Tolerance via miRNAssimilar to the inhibition of PI-3K, gave rise to a proinflammatory
phenotype. This suggests that the proinflammatory phenotype
of PI-3K inhibition is, at least partly, due to Akt1 because despite
the fact that Akt2 and Akt3 are also regulated by PI-3K, they are
functionally inert with regard to negative feedback signals in
macrophages. All Akt isoforms are expressed in macrophages
with Akt1 and Akt2 being expressed at higher amounts than
Akt3 (Shiratsuchi and Basson, 2007), but hyperresponsiveness
to LPS appeared to be a specific attribute of Akt1/ macro-
phages because the ablation of Akt2 was associated with hypo-
responsiveness to the same stimulus both in culture and in vivo
(data not shown).
The unique role of Akt1 is also supported by earlier studies that
had shown that Akt1/ Apoe/mice produce large amounts of
proinflammatory mediators that promote the development of
atherosclerosis (Fernandez-Hernando et al., 2007). However,
this study suggested that the proatherogenic phenotype
promoted by Akt1 ablation primarily depends on endothelial
cell dysfunction and production of proinflammatory mediators.
Here, we showed that macrophages were also affected by
Akt1 ablation and contribute to a proinflammatory phenotype.
Moreover, we demonstrate that miRNAs mediated the aug-
mented response to TLR4 signals and genetic manipulation of
these miRNAs restored the Akt1/ proinflammatory phenotype.
Whether the proinflammatory phenotype in endothelial cells
depends on the same miRNAs remains to be determined.
Studies in Mir155/ mice have shown that miR-155
suppresses TAK1-associated binding protein 2 (TAB2), a key
molecule in the TLR4 signaling cascade, and thus inhibits
TLR4 signals in dendritic cells (Ceppi et al., 2009) and that inhibi-
tion of miR-155 in BMDMs augments the expression of several
proinflammatory mediators (Ruggiero et al., 2009), supporting
an anti-inflammatory role for miR-155. In contrast, another report
showed that miR-155 suppresses the phosphatase SHIP1
(O’Connell et al., 2009) and we showed that it suppressed
SOCS1, both negative regulators of macrophage activation.
Moreover, in vivo inhibition of miR-155 in mice suppressed
G-CSF production upon LPS treatment (Worm et al., 2009),
also supporting a proinflammatory role of miR-155. Given that
miRNAs have multiple targets and some of their targets are
also transcriptional regulators, it is likely that suppressing a single
miRNA, either in germline or with as-miRNAs, will result in a
different phenotype from that obtained when expression of
multiple miRNAs is affected. Cross-regulation between signaling
proteins andmiRNAs is highlighted by the fact that miR-155 sup-
pressed SHIP augmenting Akt kinase activity (O’Connell et al.,
2009), whereas Akt transcriptionally suppressed miR-155, indi-
cating that miRNAs and signaling proteins participate in regula-
tory loops controlling cellular responses.
In conclusion, our data suggest that Akt1 is a key molecule for
the regulation of LPS responsiveness and tolerance by regulating
miRNAs that control TLR4 and fine-tune SOCS1 expression.
Thus, systemic inhibition of Akt1, drugs for which are currently
under development,may contribute to a proinflammatory pheno-
type. Understanding the mechanism through which PI-3K andAkt1modulates the inflammatory response will allow us to selec-
tively target molecules controlling PI-3K-Akt1 signals to posi-
tively or negatively regulate the inflammatory response. Given
the importance of Akt and miRNAs in cancer and other human
diseases, these findings may have translational implications.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 mice were purchased from the Hellenic Pasteur Institute (Athens,
Greece). Akt1/ and Akt1+/+ mice (Mao et al., 2007; Maroulakou et al.,
2007) were housed at the University of Crete School of Medicine, Greece.
All procedures described belowwere approved by the Animal Care Committee
of the University of Crete School of Medicine, Heraklion, Crete, Greece, by the
Veterinary Department of the Heraklion Prefecture, Heraklion, Crete, Greece,
and by the DLAM at TUFTS-Medical Center, Boston, USA.
Cell Culture
The murine macrophage cell line RAW264.7 and primary murine peritoneal
macrophages were cultured as previously described (Arranz et al., 2008).
E.coli-derived LPS (1 mg/ml) (O111:B4; catalog no. L2630; Sigma-Aldrich)
was used as described in the Results.
Isolation of Total RNA and Real-Time RT-PCR
Total-cellular RNA was isolated with TRIzol Reagent (Invitrogen). cDNA was
prepared by reverse transcription (Thermoscript RT; Invitrogen) and amplified
by PCR with the following primers: b-actin, 50-TCAGAAGAACTCCTATGTG
G-30/50-TCTCTTTGATGTCACGCA CG-30; SOCS1, 50-TCTATTGGGGACCCC
TGAG-30/50-GAAGCCATCTTCACGCTGAG-30. Detection of TLR4 mRNA was
performed as previously described (Medvedev et al., 2000; Nomura et al.,
2000; Tsatsanis et al., 2006). Amplification was performed as in an ABI PRISM
7000 Real-Time PCR engine. The amplification efficiency of the TLR4 and
SOCS1was the same as the one of b-actin as indicated by the standard curves
of amplification, allowing us to use the formula: fold difference = 2(DCtA DCtB),
where Ct is the cycle threshold. Reactions were performed in triplicate for
statistical evaluation.
Flow Cytometry Analysis and Cell Sorting
Cells were washed twice with PBS containing 1% BSA. Nonspecific binding
was blocked with Fc-block (BDBiosciences). Washed cells were resuspended
in a 1:200 dilution of PE-conjugated anti-mouse TLR4 antibody (clone
MTS510; e-Bioscience) or the anti-mouse pan-macrophage marker F4/80
(Clone BM8- eBioscience). Stained cells were washed twice with PBS contain-
ing 1% BSA, and they were analyzed by flow cytometry (FACSCalibur, BD
Biosciences, and CyAn, DAKO). Sorting of F4/80 stained macrophages was
performed in a MoFlo cell sorter (DAKO).
LPS-Induced Endotoxin Shock and ELISA Assays
For titration of the dose of LPS,mice received i.p. injections of 1, 1.5, or 2mg of
LPSper 25 g of bodyweight. LPSwas dissolved prior to injection in phosphate-
buffered saline at a concentration of 10 mg/ml. Injected animals were moni-
tored for a 24 hr period, and they were sacrificed when moribund. The results
showed that theminimal lethal dose of LPSwas 1.5mg (data not shown), which
was used in the subsequent experiments.Cytokine concentration in serumwas
determinedbyenzyme-linked immunoabsorbent assay (ELISA) at the indicated
time points. ELISA assaysmeasuring cytokine concentration in serum samples
and in culture supernatants were carried out with ELISA kits (R&D Systems) or
a bead-based ELISA assay (Lincoplex-Millipore).
MicroRNA and pri-miRNA Expression
The expression profile of 365 microRNAs was addressed with TaqMan micro-
RNAmicroarrays as previously described (Thum et al., 2007). The results were(H) TLR4 and SOCS1 mRNA expression was measured in the same samples as (G).
(I) TLR4 expression was measured by flow cytometry analysis in F4/80+ cells, and SOCS1 was measured by immunoblotting in spleens from the same animals.
Results are representative of three mice per strain.Immunity 31, 220–231, August 21, 2009 ª2009 Elsevier Inc. 229
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Primer Sets, in accordance with the manufacturer’s instructions (Ambion).
Expression of RNU48 was used as an internal control. Expression of pri-
miRNAs was determined with the following primers: for pri-let-7e: forward:
50-TTCTGGTCTCCCATCAATCC-30 and reverse 50-CAGAGAAGACACCCCAG
CTC-30; for pri-miR-155: forward 50-ACCCTGCTGGATGAACGTAG-30 and
reverse 50-CATGTGGGCTTGAAGTTGAG-30; for pri-miR-181c: forward: 50-AC
CCTGGAGGGTTAGGTGTT-30 and reverse: 50-CAGACTTCATTCCCGCTCAT-30;
for pri-miR-125b: forward: 50-AGCAAGGGTTTCACCATGAC-30 and reverse:
50-CACACCCAAAGCGATGTTTA-30; 18S was used as an internal control.
Potential miRNA targets were identified with the miRBase (http://microrna.
sanger.ac.uk/), PicTar (http://pictar.bio.nyu.edu/), and TargetScan version
4.0 (http://www.targetscan.org/index.html) search engines. For optimizing
the accuracy of prediction, a given target should be predicted by a minimum
of two out of three programs and the targeted sequence should be conserved
among species.
Immunoblot Analysis
Detection of SOCS1 protein was performed by immunoblot analysis as previ-
ously described (Dumitru et al., 2000). SOCS1 was detected with a polyclonal
SOCS1 antibody (ZYMED-Invitrogen), and protein loading was determined
with a monoclonal tubulin antibody (SIGMA). Proteins were visualized with
the ECL Western blotting kit (ECL Amersham Biosciences), and blots were
exposed to Kodak X-Omat AR films.
Transfection of myrAkt1, miRNAs, and Antisense miRNAs
BMDMs were differentiated as previously described (Dumitru et al., 2000).
After differentiation, cells were seeded in six-well plates and infected with
a retrovirus expressing myristyolated Akt1 and GFP under the control of two
distinct CMV promoters. Seventy-two hours later, almost all cells (>90%)
expressed Akt1 and GFP as determined by fluorescence microscopy and
FACS analysis. Raw264.7 cells were infected with the myr-Akt1-GFP retro-
virus with the same procedure. In parallel experiments, a plasmid expressing
Akt1 and GFP under CMV promoters was transfected in Raw264.7 cells with
lipofectamine 2000 (Invitrogen) and GFP expressing cells were sorted and
analyzed (Dako cytomation sorter).
For miRNA tranfection studies, Raw264.7 cells were seeded in six-well
plates and were transfected with 50 nM of miRNAs let-7e and miR-155, with
antisense miRNAs as-let-7e and as-miR-155 (Ambion), or with a Scrambled
miRNA (SCR-miRNA, Ambion Cat#AM17110), through use of the transfection
agent siPORT NeoFX. RNA was extracted at different time points (0, 6, 12, 24,
and 48 hr) after microRNA transfection, and real-time PCR analysis was per-
formed as described above.
Luciferase Assays
The 30 UTR of murine TLR4 and murine SOCS1 was cloned in the pMIR-
REPORT-luciferase vector (Ambion) as described in Supplemental Experi-
mental Procedures.
Constructs were transfected in Raw264.7 and luciferase activity was
measured with the Luciferase Reporter Assay System (Promega).
Statistical Analysis
All values are expressed as the mean ± SEM of data obtained from at least
three experiments. Comparison between groups was made with the Student’s
t test and ANOVA test. Log Rank analysis was used for survival experiments.
p < 0.05 was the significance level.
ACCESSION NUMBERS
The results of the miRNA arrays are available in the Gene Expression Omnibus
(GEO) database (http://www.ncbi.nlm.nih.gov/geo/). The accession number is
GSE17421.
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